The FDA's Center for Devices and Radiological Health will continue working to tap other regulators' data to improve risk evaluations of medical-device production plants, Office of Compliance Director Timothy Ulatowski said. Ulatowski will attend the fifth annual Medical Device Quality Congress this week to discuss the CDRH's priorities.

Full Story:

Related Summaries